Stay In The Know
Join The Discord & Study Up With The Foundation Video Series https://tradejournal.co/connect
Live Stream
Timestamps in video description
News
MorningBrew Referral I need 4 More for stickersss!!! Do it.
https://www.morningbrew.com/daily/r?kid=96d33aa0
After Stimulus, Biden to Tackle Another Politically Tricky Issue: Infrastructure
The Costs and Benefits of a $15 Federal Minimum Wage
Ripples from Bukele's big win
https://us12.campaign-archive.com/?u=7404e6dcdc8018f49c82e941d&id=f9107a1046
Notes / Research / Recap / Additional Video
Monthly Mentioned Tickers
- RMGB
- Indias largest renewable energy company gets SPAC deal
- Backed by palihapitiya
Merch Coupons & Help!
420 Art is live for Team Winkler on Jeff's website (10% discount code: “AWinkler)
https://www.jeffthe420chef.com/shop?Product+Type=420+Art
Tulip mania art work - (10% Off Code: AlexWinkler)
Ideas
kyle Great
- A. Winkler shirt- looks like a jersey, and on the back where the name would go, “tricky tickler"
3:46 PMRB
- Alex's catch phrase "It is what it is"
Watchlist
| KMPH [NASD] |
| KemPharm, Inc. |
| Healthcare | Biotechnology | USA |
60% 163mc 4f
| Mar-02-21 11:31PM | |
| 08:01AM |
| OCGN [NASD] |
| Ocugen, Inc. |
| Healthcare | Biotechnology | USA |
42% 1,320mc 157f
Covid vaccine dev partner says 81% efficacy
| Feb-26-21 06:57AM |
Motley Fool +36.87%
|
| Feb-24-21 06:09AM |
| SLGG [NASD] |
| Super League Gaming, Inc. |
| Communication Services | Electronic Gaming & Multimedia | USA |
25% 85mc 14f
| Mar-01-21 04:11PM |
Benzinga +6.07%
|
| Feb-10-21 08:00AM |
GlobeNewswire
|
| OVID [NASD] |
| Ovid Therapeutics Inc. |
| Healthcare | Biotechnology | USA |
40% 187mc 42f
March 3, 2021 07:02 AM ET (BZ Newswire) -- News
− Ovid eligible to receive up to $856M in payments, including a $196M upfront payment, regulatory and commercial milestone payments and tiered double-digit royalties on product sales
− Potential first-in-class therapy reduced seizure frequency in children with Dravet syndrome and Lennox-Gastaut syndrome in Phase 2 ELEKTRA study
− Original 2017 collaboration between Ovid and Takeda to conclude; Ovid will have no further development or milestone obligations
− Takeda plans to initiate Phase 3 studies in children and adults with Dravet syndrome and Lennox-Gastaut syndrome in calendar year Q2 2021
− Ovid will hold a conference call and webcast today at 8:30 a.m. EST
| Jan-15-21 02:22AM | |
| Dec-16-20 07:00AM |
GlobeNewswire +6.59%
|
| TRXC [AMEX] |
| Asensus Surgical, Inc. |
| Healthcare | Medical Devices | USA |
30% 570mc 98f
| Mar-03-21 06:55AM | |
| Mar-01-21 05:45PM |
| COHN [AMEX] |
| Cohen & Company Inc. |
| Financial | Capital Markets | USA |
120% 24mc 0.5f
| Mar-03-21 08:00AM |
GlobeNewswire +125.07%
|
| Mar-01-21 04:15PM |
Free Gap Scanner + Win 2 Free Stocks 🎉 (Each Up To $1600) 👉👉 http://enzlo.com/webull
Best Savings Account Ever! 😍 Win $10 Million - Use Code: WINKLER 👉👉 http://enzlo.com/save
Watchlist 👉👉 https://tradejournal.co/post/wednesday-pre-market-top-gainers-432/
